BridgeMD
Compares treatment options for Transfusion
Official title Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
ClinicalTrials.gov ID: NCT06560164
What this study is testing
- What it's testing
- Rationale: In patients supported with extracorporeal membrane oxygenation (ECMO), transfusion of red blood cells (RBC) is very common. This is possibly due to the application of liberal thresholds and the lack of evidence-based guidelines.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient is aged 18 years or older;
- Is receiving ECMO;
- (Deferred) informed consent.
You likely can't join if
- Not expected to survive for 24 hours when assessed;
- Inability to receive blood products;
- (Known) decline to blood transfusions (e.g., Jehovah's Witnesses);
- Extracorporeal carbon dioxide removal (ECCO2R) using low blood flow devices or pumpless devices (i.e., MINILUNG ®, PrismaLung+);
- Received ECMO over 48h before screening for eligibility.
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Brussels Capital, Belgium
- Leuven, Flemish Brabant, Belgium
- Charleroi, Hainaut, Belgium
- Enschede, Drenthe, Netherlands
- Maastricht, Limburg, Netherlands
- Amsterdam, North Holland, Netherlands
- Groningen, Provincie Groningen, Netherlands
- Leiden, South Holland, Netherlands
- Rotterdam, South Holland, Netherlands
- Nieuwegein, Utrecht, Netherlands
- Stockholm, Stockholm County, Sweden
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Brussels Capital, Belgium; Leuven, Flemish Brabant, Belgium; Charleroi, Hainaut, Belgium; Enschede, Drenthe, Netherlands; Maastricht, Limburg, Netherlands; Amsterdam, North Holland, Netherlands and 5 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.